These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

837 related articles for article (PubMed ID: 30013539)

  • 1. Nano-Strategies to Fight Multidrug Resistant Bacteria-"A Battle of the Titans".
    Baptista PV; McCusker MP; Carvalho A; Ferreira DA; Mohan NM; Martins M; Fernandes AR
    Front Microbiol; 2018; 9():1441. PubMed ID: 30013539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ins and outs of RND efflux pumps in Escherichia coli.
    Anes J; McCusker MP; Fanning S; Martins M
    Front Microbiol; 2015; 6():587. PubMed ID: 26113845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymol-Decorated Gold Nanoparticles for Curing Clinical Infections Caused by Bacteria Resistant to Last-Resort Antibiotics.
    Huang Z; Zhang X; Yao Z; Han Y; Ye J; Zhang Y; Chen L; Shen M; Zhou T
    mSphere; 2023 Jun; 8(3):e0054922. PubMed ID: 37017551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mechanistic perspective on targeting bacterial drug resistance with nanoparticles.
    Khorsandi K; Keyvani-Ghamsari S; Khatibi Shahidi F; Hosseinzadeh R; Kanwal S
    J Drug Target; 2021 Nov; 29(9):941-959. PubMed ID: 33703979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticles as therapeutic options for treating multidrug-resistant bacteria: research progress, challenges, and prospects.
    Mba IE; Nweze EI
    World J Microbiol Biotechnol; 2021 May; 37(6):108. PubMed ID: 34046779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The challenges and applications of nanotechnology against bacterial resistance.
    Lei Z; Karim A
    J Vet Pharmacol Ther; 2021 May; 44(3):281-297. PubMed ID: 33277732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focused review on dual inhibition of quorum sensing and efflux pumps: A potential way to combat multi drug resistant Staphylococcus aureus infections.
    Kaur B; Gupta J; Sharma S; Sharma D; Sharma S
    Int J Biol Macromol; 2021 Nov; 190():33-43. PubMed ID: 34480904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology as a Novel Approach in Combating Microbes Providing an Alternative to Antibiotics.
    Mubeen B; Ansar AN; Rasool R; Ullah I; Imam SS; Alshehri S; Ghoneim MM; Alzarea SI; Nadeem MS; Kazmi I
    Antibiotics (Basel); 2021 Nov; 10(12):. PubMed ID: 34943685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biofilms as Promoters of Bacterial Antibiotic Resistance and Tolerance.
    Uruén C; Chopo-Escuin G; Tommassen J; Mainar-Jaime RC; Arenas J
    Antibiotics (Basel); 2020 Dec; 10(1):. PubMed ID: 33374551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial Biofilm and Quorum Sensing Inhibition: Endowment of Medicinal Plants to Combat Multidrug-Resistant Bacteria.
    Das R; Mehta DK
    Curr Drug Targets; 2018; 19(16):1916-1932. PubMed ID: 29623836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial Multidrug Efflux Pumps at the Frontline of Antimicrobial Resistance: An Overview.
    Huang L; Wu C; Gao H; Xu C; Dai M; Huang L; Hao H; Wang X; Cheng G
    Antibiotics (Basel); 2022 Apr; 11(4):. PubMed ID: 35453271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Mini-review on Recent Strategies and Applications of Nanomedicines to Combat Antimicrobial Resistance.
    Chahar K; Sharma Y; Patel P; Asati V; Das Kurmi B
    Curr Drug Metab; 2023; 24(6):406-421. PubMed ID: 37519199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promising advances in nanobiotic-based formulations for drug specific targeting against multidrug-resistant microbes and biofilm-associated infections.
    Elfadil D; Elkhatib WF; El-Sayyad GS
    Microb Pathog; 2022 Sep; 170():105721. PubMed ID: 35970290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.
    Medina E; Pieper DH
    Curr Top Microbiol Immunol; 2016; 398():3-33. PubMed ID: 27406189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotechnology as a Promising Approach to Combat Multidrug Resistant Bacteria: A Comprehensive Review and Future Perspectives.
    Hetta HF; Ramadan YN; Al-Harbi AI; A Ahmed E; Battah B; Abd Ellah NH; Zanetti S; Donadu MG
    Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of bacterial biocide and antibiotic resistance.
    Poole K
    Symp Ser Soc Appl Microbiol; 2002; (31):55S-64S. PubMed ID: 12481829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Nanotherapeutics as Next-generation Anti-infective Agents: Current Trends and Future Prospectives.
    Subhaswaraj P; Syed A; Siddhardha B
    Curr Drug Discov Technol; 2020; 17(4):457-468. PubMed ID: 31309893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metallic Nanosystems in the Development of Antimicrobial Strategies with High Antimicrobial Activity and High Biocompatibility.
    Skłodowski K; Chmielewska-Deptuła SJ; Piktel E; Wolak P; Wollny T; Bucki R
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efflux Pump Mediated Antimicrobial Resistance by Staphylococci in Health-Related Environments: Challenges and the Quest for Inhibition.
    Dashtbani-Roozbehani A; Brown MH
    Antibiotics (Basel); 2021 Dec; 10(12):. PubMed ID: 34943714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Confronting antibiotic-resistant pathogens: Distinctive drug delivery potentials of progressive nanoparticles.
    Chatterjee P; Chauhan N; Jain U
    Microb Pathog; 2024 Feb; 187():106499. PubMed ID: 38097117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.